Daily Archives: February 13, 2022
Pfizer and FDA pull back from plan to expedite review of Covid-19 vaccine in children under 5.
13 Feb, 2022 | 22:51h | UTCPfizer and FDA pull back from plan to expedite review of Covid-19 vaccine in young children – STAT
See also:
COVID-19 vaccine for kids under 5 delayed as Pfizer extends trial – CIDRAP
Pfizer postpones FDA request for Covid vaccine for kids under 5 – NBC News
WHO’s new International Classification of Diseases (ICD-11) comes into effect.
13 Feb, 2022 | 22:56h | UTCNews Release: WHO’s new International Classification of Diseases (ICD-11) comes into effect – World Health Organization
See also:
Commentary on Twitter
? The latest update for the 11th Revision of the International Classification of Diseases (ICD-11) is now online!#ICD11 is a 'common language' for health professionals to share standardized health information around the world.
Learn more https://t.co/M2yu9md9fm pic.twitter.com/jv2IbEkD5u— World Health Organization (WHO) (@WHO) February 11, 2022
Novavax says protein vaccine works for kids as young as 12.
13 Feb, 2022 | 22:54h | UTCNovavax says protein vaccine works for kids as young as 12 – Associated Press
Press Release: Novavax Announces Positive Results of COVID-19 Vaccine in Pediatric Population of PREVENT-19 Phase 3 Clinical Trial
Related:
Opinion | The mRNA vaccines are extraordinary, but Novavax is even better.
RCT: Novavax vaccine is 49.4% effective against B.1.351 SARS-CoV-2 variant.
New COVID-19 vaccines: here’s how the promising Novavax and Johnson & Johnson jabs work
Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant
Covid-19: What do we know about omicron sublineages?
13 Feb, 2022 | 22:42h | UTCCovid-19: What do we know about omicron sublineages? – The BMJ
Related:
We regret to inform you that we are now discussing subvariants – Vox
Sudden rise of more transmissible form of Omicron catches scientists by surprise.
Omicron’s sister variant spreads faster. So why did the one we call Omicron hit first?
BA.2 is like Omicron’s sister. Here’s what we know about it so far – The Conversation
Commentary on Twitter
In November 2021 WHO designated omicron a variant of concern. With its sublineage BA.2 now widespread, @emahase_ looks at what science has found out about the variant and its three (so far) variations https://t.co/HjBZSwCATW
— The BMJ (@bmj_latest) February 13, 2022
Conflicting reports raise questions about whether any monoclonals work against Omicron’s sister variant.
13 Feb, 2022 | 22:49h | UTCRelated:
FDA halts use of antibody drugs that don’t work vs. Omicron.
ERS statement on Long COVID-19 follow-up.
13 Feb, 2022 | 22:48h | UTCEuropean Respiratory Society Statement on Long COVID-19 Follow-Up – European Respiratory Review
First research definition for ‘Long COVID’ in kids and young people formally agreed.
13 Feb, 2022 | 22:45h | UTCNews Release: First research definition for ‘Long COVID’ in kids and young people formally agreed – BMJ
Original Article (preprint): Long COVID (Post-COVID-19 condition) in Children: a modified Delphi Process – Archives of Disease in Childhood
Commentaries:
Long covid: “Holistic” approach is best, given range of symptoms, say researchers – The BMJ
Related:
Editorial | Long covid in children and adolescents – “Risk appears low, but many questions remain”.
Review: Long COVID symptoms in children rarely persist beyond three months.
Special Issue: Evidence-based strategies for better antibiotic prescribing in primary care.
13 Feb, 2022 | 22:40h | UTCEditorial: Antibiotic stewardship – Australian Journal of General Practice
Evidence-based strategies for better antibiotic prescribing – Australian Journal of General Practice
RCT: Effects of a 6-month, low-carbohydrate diet on glycemic control, body composition, and cardiovascular risk factors in patients with type 2 diabetes.
13 Feb, 2022 | 22:35h | UTC
RCT: Primary Norfloxacin prophylaxis prevents bacterial infections in patients with acute-on-chronic liver failure.
13 Feb, 2022 | 22:37h | UTCPrimary Norfloxacin Prophylaxis for APASL-Defined Acute-on-Chronic Liver Failure: A Placebo-Controlled Double-Blind Randomized Trial – The American Journal of Gastroenterology (link to abstract – $ for full-text)
WHO Guideline: Hypertension pharmacological treatment in adults.
13 Feb, 2022 | 22:23h | UTC
2022 SCCM Guidelines on prevention and management of pain, agitation, neuromuscular blockade, and delirium in critically ill pediatric patients with consideration of the ICU environment and early mobility.
13 Feb, 2022 | 22:19h | UTC
Commentary on Twitter
New in #PANDEM guidelines for infants & children: guidance on nonpharmacological interventions that can lead to better outcomes:
✅ Music
✅ Physical
✅ Occupational
✅ Child life
What interventions have worked well for you?
Guidelines: https://t.co/lMfFsiEPeV#SCCMSoMe #PedsICU pic.twitter.com/BLksVV0pNo— SCCM (@SCCM) February 4, 2022
AAST Consensus: Rhabdomyolysis.
13 Feb, 2022 | 22:21h | UTC
FIMS / EFSMA Joint position statement on the International Olympic Committee framework on fairness, inclusion and non-discrimination based on gender identity and sex variations.
13 Feb, 2022 | 22:17h | UTCOriginal Guidance: IOC Framework on fairness, inclusion and non-discrimination on the basis of gender identity and sex variations – International Olympic Committee
Commentary: International Olympic Committee transgender guidance criticised by medical experts – BBC
Commentary on Twitter
You do not have to agree with all content in this position statement. But surely we can agree that we need further debate and discussion (and consultation with all stakeholders) to protect the rights of all athletes. #OpenAccess ➡️ https://t.co/xIfnsyk7FV#Diversity #Inclusion pic.twitter.com/2c9S8lGCoa
— BMJ Open Sport & Exercise Medicine (@BMJOpenSEM) January 20, 2022
RCT: In patients with cardiogenic shock receiving VA-ECMO, moderate hypothermia did not significantly reduce 30-day mortality. 42% of patients in the moderate hypothermia group died vs. 51% in the normothermia group (adjusted odds ratio, 0.71 [95% CI, 0.45 to 1.13], P = .15).
13 Feb, 2022 | 22:11h | UTCEffect of Moderate Hypothermia vs Normothermia on 30-Day Mortality in Patients With Cardiogenic Shock Receiving Venoarterial Extracorporeal Membrane Oxygenation: A Randomized Clinical Trial – JAMA (link to abstract – $ for full-text)
Commentary: Hypothermia vs. Normothermia for Cardiogenic Shock Patients on VA-ECMO – American College of Cardiology
Commentary on Twitter
In this RCT, for patients with cardiogenic shock receiving venoarterial ECMO, moderate hypothermia for 24 hours compared with normothermia did not significantly decrease 30-day mortality. https://t.co/0LKYJ1bNB3 pic.twitter.com/KmXPAlvqh9
— JAMA (@JAMA_current) February 2, 2022
RCT: In patients with contaminated ventral hernias undergoing repair, synthetic Mesh reduced hernia recurrence risk compared with biologic Mesh.
13 Feb, 2022 | 22:05h | UTCBiologic vs Synthetic Mesh for Single-stage Repair of Contaminated Ventral Hernias: A Randomized Clinical Trial – JAMA Surgery (link to abstract – $ for full-text)
Commentary on Twitter
Multicenter randomized clinical trial found synthetic mesh demonstrated significantly lower hernia recurrence risk than biologic mesh in patients undergoing single-stage repair of clean-contaminated and contaminated ventral hernias. https://t.co/CADZPSYGBc
— JAMA Surgery (@JAMASurgery) January 19, 2022
Opinion | There’s no autism epidemic. But there is an autism diagnosis epidemic.
13 Feb, 2022 | 22:02h | UTCThere’s no autism epidemic. But there is an autism diagnosis epidemic – STAT
Opinion: Time to retire the concept of Transient Ischemic Attack.
13 Feb, 2022 | 22:01h | UTCTime to Retire the Concept of Transient Ischemic Attack – JAMA (free for a limited period)
Commentary on Twitter
After spending my entire career studying TIAs, Don Easton and I are recommending we retire the term. It isn't clear that TIAs ever existed, at least as they were conceptualized. Rise up Acute Ischemic Cerebrovascular Event/Syndrome. https://t.co/FeG31pPHey
— Clay Johnston (@ClayJohnstonMD) February 11, 2022
Sleep assessment in critically ill adults: established methods and emerging strategies.
13 Feb, 2022 | 21:55h | UTC
Commentary on Twitter
#CritCareExplore @SCCM Critically ill patients sleep poorly while in the ICU with potential implications for several important outcomes. This review summarizes both current methods and new strategies to measure sleep in these challenging environments. https://t.co/2jtpHe4MKp pic.twitter.com/c5jnqwR3Mh
— Critical Care Explorations (@CritCareExplore) February 12, 2022
Study shows a lack of association of Group A Streptococcal infections and onset of tics.
13 Feb, 2022 | 22:04h | UTCLack of Association of Group A Streptococcal Infections and Onset of Tics: European Multicenter Tics in Children Study – Neurology (link to abstract – $ for full-text)
News Release: Does strep throat lead to the development of tics? – American Academy of Neurology
Commentaries:
Strep Does Not Lead to Tics, Study Finds – NeurologyToday
Group A Strep Infection Not Tied to Tics in Children With Family History – HealthDay
Commentary on Twitter
Very important study to further remove us away from Group-A streptococcal infections and tics in families with primary tic disorders! https://t.co/HwHVrxNSqJ
— Christos Ganos (@ChristosGanos) February 9, 2022
Review: Management of venous thromboembolism in pregnancy.
13 Feb, 2022 | 21:57h | UTCManagement of venous thromboembolism in pregnancy – Thrombosis Research
Related:
Management of high-risk pulmonary embolism in pregnancy.
Study: Diagnosis of Pulmonary Embolism During Pregnancy
Imaging is the only way to diagnose blood clots in pregnancy
ED management of the post-laryngectomy patient.
13 Feb, 2022 | 21:44h | UTCED Management of the Post-Laryngectomy Patient – emDocs
Review: Global accessibility of therapeutics for diabetes mellitus.
13 Feb, 2022 | 21:51h | UTCGlobal accessibility of therapeutics for diabetes mellitus – Nature Reviews Endocrinology (if the link is paywalled, try this one)
Related:
Editorial | Insulin for all: a hope yet to be realized.
One hundred years of insulin therapy.
Betibeglogene Autotemcel gene therapy for Non–beta0/beta0 Genotype beta-thalassemia.
13 Feb, 2022 | 21:46h | UTCBetibeglogene Autotemcel Gene Therapy for Non–β0/β0 Genotype β-Thalassemia – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary on Twitter
Visual Abstract: Betibeglogene Autotemcel Gene Therapy for Non–β0/β0 Genotype β-Thalassemia. https://t.co/2GOCGxrruv pic.twitter.com/zLvuuuByXN
— NEJM (@NEJM) February 8, 2022
Aromatase inhibitors vs. tamoxifen in premenopausal women with estrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomized trials
13 Feb, 2022 | 21:32h | UTCCommentaries:
Aromatase Inhibitors May Benefit Premenopausal Women With Breast Cancer – HealthDay